February 4, 2025 - 15:43

In a significant shift in policy, the Trump administration has effectively halted activities at the U.S. Agency for International Development (USAID), raising concerns about the future of international health assistance. Senior officials at the agency have been placed on administrative leave as the administration reevaluates its approach to foreign aid.
This disruption comes at a time when global health initiatives are critical, particularly in light of ongoing health crises around the world. The decision has sparked widespread criticism from health advocates and international organizations, who argue that U.S. support is vital for combating diseases, addressing humanitarian needs, and promoting global health security.
The fate of USAID hangs in the balance as the administration weighs its options. Stakeholders are urging a swift resolution to ensure that essential health programs continue to receive the funding and support they require. The implications of this policy shift could have lasting effects on international health efforts and the U.S.'s role in global health leadership.
July 2, 2026 - 04:03
VA health secretary quits less than a year into tenureJohn Bartrum, the official who oversaw the Veterans Health Administration`s troubled rollout of a new electronic health records system, has resigned from his post less than a year after taking the...
July 1, 2026 - 08:37
Anglia Ruskin mental health nursing course under reviewThe Nursing and Midwifery Council has called for an `extraordinary review` of the mental health nursing course at Anglia Ruskin University. The regulatory body`s decision comes amid concerns over...
June 30, 2026 - 22:44
Politics: High Cost Of Healthcare And The Political FalloutAmericans are feeling the squeeze of rising healthcare expenses like never before. For the first time in five years, fewer than half of U.S. adults say they can consistently afford medical care,...
June 30, 2026 - 15:13
Top GLP-1 prescription indications include sleep apnea, depression and kidney disease, study findsA new analysis of insurance claims data reveals that prescriptions for GLP-1 medications are increasingly being approved for conditions far beyond their original use for diabetes and weight loss....